Skip to main content

Month: February 2024

Correction: Convocation of the Extraordinary General Meeting of Shareholders of Snaigė AB

Correction: The Meeting’s accounting day – 13 February 2024.   On 21 February 2024 the Extraordinary General Meeting of Shareholders of Snaigė AB, the address of head office Pramonės str. 6, Alytus, the company code 249664610 (hereinafter, the “Company”) is convened (hereinafter, the “Meeting”). The place of the meeting –at AB “Snaige” office, at the address Pramonės str. 6, Alytus, Lithuania. The Meeting commences – at 10 a.m. (registration starts at 9.45 a.m.). The Meeting’s accounting day – 13 February 2024 (the persons who are shareholders of the Company at the end of accounting day of the General Meeting of Shareholders or authorized persons by them, or the persons with whom shareholders concluded the agreements on the disposal of voting right, shall have the right to attend and vote at the General Meeting of Shareholders). Agenda...

Continue reading

Umbra Companies, Inc Shareholder Update

GREENWOOD VILLAGE, Colo., Feb. 02, 2024 (GLOBE NEWSWIRE) — Dear Fellow Shareholders, The team at Umbra Companies, Inc (UCIX) would like to take this opportunity to thank our shareholders and express our excitement about what we strongly believe will be a very fruitful and growth-positive 2024. Umbra continues to achieve critical milestones, and we look forward to releasing some of these exciting developments in the coming weeks and months. The Company continues to solidify and expand its real estate portfolio, working to complete several key acquisitions as it seeks to identify exciting new opportunities. As Umbra continues to negotiate land for various residential projects in the Las Vegas, NV area, Umbra will actively seek to execute the following:Apply to The International Stock Exchange (TISE) File a 506 c for accredited...

Continue reading

Vehicle Telematics Market Set to Soar Past USD 211.57 Billion by 2030 | Skyquest Technology

The vehicle telematics market is poised for growth from 2023 to 2030, driven by technology options such as embedded, tethered, and integrated systems. These solutions are distributed through sales channels including OEMs and the aftermarket, shaping the industry landscape. Westford, USA, Feb. 02, 2024 (GLOBE NEWSWIRE) — The global Vehicle Telematics market size is expected to reach USD 211.57 billion by 2030 and exhibit a CAGR of 15.8% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing demand for vehicle tracking and fleet management solutions to enhance operational efficiency and reduce operating costs. Safety concerns and regulatory mandates have led to adoption of telematics systems for driver behavior monitoring and accident prevention. The desire for real-time connectivity...

Continue reading

Global Smart Inhalers Market to Surpass 51.85 Billion by 2030 Driven by Increasing Prevalence of Chronic Respiratory Diseases

SkyQuest projects that the global smart inhalers market will attain a value of USD 51.85 billion by 2030, with a CAGR of 19.8% during the forecast period (2023-2030). The global smart inhalers market represents a swiftly expanding segment within the healthcare industry, heralding a transformative era in managing respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Westford, USA, Feb. 02, 2024 (GLOBE NEWSWIRE) — According to SkyQuest, the increasing prevalence of chronic respiratory diseases (CRDs) worldwide, coupled with the prospect of achieving improved clinical outcomes, is anticipated to be a substantial catalyst for the growth of the global smart inhalers market. A heightened demand for advanced and more effective treatment options with CRDs such as asthma, chronic obstructive pulmonary disease...

Continue reading

Tissue Engineering Market Set to Soar Past USD 32.45 Billion by 2030

The global Tissue Engineering market size is expected to reach USD 32.45 billion by 2030 and exhibit a CAGR of 10.7% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing prevalence of chronic diseases and injuries requiring tissue replacements, advancements in regenerative medicine and biotechnology, rising demand for organ transplantation alternatives, a growing aging population with higher healthcare needs, and expanding research and development initiatives in tissue engineering are fueling the market’s growth. Westford, USA, Feb. 02, 2024 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Tissue Engineering market, development of 3D bioprinting techniques for precise tissue fabrication, increased focus on stem cell therapies and gene editing...

Continue reading

Pressure Sensitive Adhesives Market Set to Soar Past USD 16.71 Billion by 2030

The global Pressure Sensitive Adhesives market size is expected to reach USD 16.71 billion by 2030 and exhibit a CAGR of 4.3% in the forecast period (2023−2030), according to Skyquest’s latest research report. The growing demand from the packaging industry for labeling and flexible packaging applications, increasing adoption in the automotive sector for lightweight bonding solutions, expanding electronics and electrical industry for device assembly, rising use in medical applications for wound care and device attachment, and the trend toward sustainable and environmentally friendly adhesive products is fueling the market’s growth. Westford, USA, Feb. 02, 2024 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Pressure Sensitive Adhesives market, growing demand for low-VOC and environmentally...

Continue reading

Year-End Report January 1 – December 31, 2023

Net asset value on December 31, 2023, was SEK 150.3 billion, or SEK 348 per share. During the year, net asset value increased by 19%, corresponding to SEK 55 per share. On February 1, 2024, net asset value was SEK 341 per share. The total return for 2023 was 33% for the Class A shares, as well as for the Class C shares, compared with 19% for the Stockholm Stock Exchange’s total return index (SIXRX). During the year, shares were purchased for a total of SEK 2.9 billion, of which SEK 1.1 billion in Sandvik, SEK 0.9 billion in Volvo, SEK 0.6 billion in Handelsbanken and SEK 0.2 billion in SCA. The Board of Directors proposes a dividend of SEK 7.75 per share (7.25).    2023 2022    Dec 31 Dec 31Net asset value, SEK M   150,252 126,477Net asset value per share, SEK   348 293Share price Industrivärden C, SEK   328.30 253.00Debt-equities...

Continue reading

United-Guardian Announces Dividend Increase

HAUPPAUGE, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) — United-Guardian, Inc. (NASDAQ:UG) announced today that the company’s Board of Directors, at its meeting on January 30, 2024, declared a cash dividend of $0.25 per share, to be paid on February 20, 2024, to all stockholders of record as of the close of business on February 12, 2024. This will be the 29th consecutive year that the company has paid a dividend. Donna Vigilante, President of United-Guardian, stated, “I am pleased to report that the company’s Board of Directors has decided to distribute a dividend of $0.25 per share to our stockholders. This dividend represents a significant increase over the $0.10 per share dividend the company paid in 2023. Even with this increase in the dividend we will still be retaining a higher percentage of the Company’s earnings than we...

Continue reading

Carboxymethyl Cellulose Market Set to Soar Past USD 2.92 Billion by 2030 | Skyquest Technology

Exploring the carboxymethyl cellulose market reveals its diverse applications, including food and beverages, oil refining, pharmaceuticals, textiles, cosmetics, paper coatings, and more. It encompasses technical and industrial grades, promising growth and innovation from 2023 to 2030. Westford USA, Feb. 02, 2024 (GLOBE NEWSWIRE) — The global Carboxymethyl Cellulose market size is expected to reach USD 2.92 billion by 2030 and exhibit a CAGR of 4.3% in the forecast period (2023−2030), according to Skyquest’s latest research report. The growing aesthetic consciousness, increasing prevalence of obesity and overweight population, advancements in technology and treatment options, rising disposable incomes, expanding beauty and wellness industry, growing demand for non-invasive and minimally invasive procedures, the influence of...

Continue reading

Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue Results

– Year-over-year unaudited revenue increased 114% for the fiscal second quarter and 337% for the six months ended December 31, 2023 – NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced preliminary unaudited revenue results for fiscal Second Quarter and six months ended December 31, 2023. The Company expects approximate unaudited revenue of $1.56 million for the six months ended December 31, 2023, representing a significant increase of 337% compared to the same period the prior year, and approximate unaudited revenue of $0.76 million for the second fiscal quarter ended December 31, 2023, representing an increase of 114% compared...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.